Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Arecor Therapeutics plc
Cambridge, United Kingdom
A
11-50 Employees
2007
Key takeaway
Arecor is a biopharmaceutical company dedicated to enhancing existing therapeutic medicines, particularly in the area of diabetes and other chronic conditions, through its innovative Arestat™ formulation technology. This focus on developing superior peptides and partnerships with leading pharmaceutical and biotech companies underscores their commitment to advancing therapies for improved patient care.
Reference
Product
Superior peptides - Arecor
Origin Peptides
Glasgow, United Kingdom
A
1-10 Employees
-
Key takeaway
The company is at the forefront of utilizing innovative peptide synthesis technology, which allows for more environmentally friendly and efficient production of peptides. Their approach not only enhances the feasibility of various applications, including enzymatic and environmental uses, but also aims to support others in advancing their peptide production needs.
Reference
Service
Our Services — Origin Peptides
Isca Biochemicals
Exeter, United Kingdom
A
1-10 Employees
2011
Key takeaway
Isca Biochemicals specializes in the synthesis and supply of high-quality peptides, offering a range of products from biological standards to advanced research tools. They provide reliable and confidential services, ensuring fully characterized peptides available in various quantities.
Reference
Product
Peptide5 | 916977-43-0 | Isca Biochemicals
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Immune Targeting Systems
London, United Kingdom
A
11-50 Employees
2003
Key takeaway
Altimmune is a clinical-stage biopharmaceutical company dedicated to developing innovative peptide-based therapeutics, particularly for obesity and liver diseases. Their lead candidate, pemvidutide, is designed as a dual receptor agonist targeting obesity and NASH.
Reference
Core business
Altimmune a clinical stage biopharmaceutical company
Altimmune a clinical stage biopharmaceutical company developing peptide-based therapeutics. Our focus is developing next generation peptide therapeutics for obesity and liver disease
Peptides Congress
Oxford, United Kingdom
A
1-10 Employees
-
Key takeaway
The company has established strong relationships with top speakers and solution providers, facilitating outstanding events that attract over 450 attendees from global pharmaceutical organizations and leading biotech companies. They also highlight the importance of academic insights in advancing the field of peptides.
Reference
Core business
Oxford Global Marketing – 5th Annual Peptides Congress – 16 – 17 April 2018, London
T-Therapeutics Ltd
Cambridge, United Kingdom
A
11-50 Employees
2022
Key takeaway
T-Therapeutics is developing innovative TCR-based therapeutics using their proprietary OpTiMus® platform, which generates unique, antigen-specific human TCRs. Their focus on harnessing T cells to combat tumors positions them at the forefront of precision medicine for cancer and autoimmune disorders.
Reference
Core business
About - T-Therapeutics
Orbit Discovery
Oxford, United Kingdom
A
11-50 Employees
2015
Key takeaway
Orbit Discovery specializes in the discovery of peptides and other small biologic-based moieties, utilizing advanced screening technologies to identify therapeutic candidates. Their focus on high throughput screening and functional assays positions them as a key player in peptide-enabled drug discovery solutions.
Reference
Core business
Orbit Discovery – Delivering Peptide Enabled Drug Discovery Solutions
Patients Cure Therapeutics
United Kingdom
A
1-10 Employees
-
Key takeaway
Patient Cure Therapeutics is a pharmaceutical company that specializes in developing treatment drugs, which may include peptide therapeutics, from preclinical trials to commercialization.
Reference
Core business
PATIENTSCURE TX | Patientscure - Tx
Patients Cure Therapeutics Limited, Clinical trial drug development
Peptides UK
London, United Kingdom
A
1-10 Employees
-
Key takeaway
The company emphasizes the significant role of peptide research in targeting and manipulating cell responses, highlighting its continuous growth as a scientific field. They offer a range of high-quality research peptides, underscoring their commitment to providing trusted products for scientific exploration.
Reference
Core business
Peptides UK - Buy Research Peptides Online
The Boldon Practice is a multidisciplinary centre for Health and Wellbeing, providing an array of professional and complementary therapies. 0191 425 0101
Activotec
Cambridge, United Kingdom
A
- Employees
-
Key takeaway
Activotec specializes in high purity amino acid derivatives and is renowned for its custom peptide synthesis, catering to the biomedical research, biotechnology, and pharmaceutical sectors. They offer a comprehensive range of peptide-related services, including the synthesis of stapled peptides and the use of advanced chemistries, ensuring adherence to the highest quality standards.
Reference
Product
Products - Activotec
Technologies which have been searched by others and may be interesting for you:
When exploring the peptide therapeutics industry in the United Kingdom, several key considerations come into play. Regulatory compliance is critical, as the UK follows stringent guidelines set by the Medicines and Healthcare products Regulatory Agency (MHRA). Understanding these regulations is essential for ensuring product safety and efficacy. The competitive landscape is marked by a mix of established pharmaceutical companies and innovative biotech firms, necessitating a thorough analysis of market players and their unique offerings. Additionally, the industry presents significant opportunities, particularly in personalized medicine and targeted therapies, driven by ongoing advancements in biotechnology. However, challenges such as high development costs, lengthy approval processes, and the complexity of peptide synthesis can pose barriers to entry. Environmental concerns are also gaining traction, with a growing emphasis on sustainable practices in the production and disposal of pharmaceutical products. Finally, the global market relevance of peptide therapeutics continues to expand, fueled by an increasing demand for novel treatments in areas such as oncology, metabolic disorders, and autoimmune diseases. Staying informed about international trends and collaborations can provide valuable insights into potential growth and investment opportunities within the UK market.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | United Kingdom |
| Amount of fitting manufacturers | 1424 |
| Amount of suitable service providers | 1081 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2003 |
| Youngest suiting company | 2022 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Peptide Therapeutics?
Start-Ups who are working in Peptide Therapeutics are T-Therapeutics Ltd
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Pharmaceuticals, Biotechnology, Other, Healthcare, Medical
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.